Positive News SentimentPositive NewsNASDAQ:TNDM Tandem Diabetes Care (TNDM) Stock Price, News & Analysis $42.40 -0.36 (-0.84%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$41.13â–Ľ$43.4650-Day Range$35.21â–Ľ$47.3052-Week Range$13.82â–Ľ$53.69Volume1.10 million shsAverage Volume1.05 million shsMarket Capitalization$2.74 billionP/E RatioN/ADividend YieldN/APrice Target$54.36 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Tandem Diabetes Care alerts: Email Address Tandem Diabetes Care MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.81 Rating ScoreUpside/Downside28.2% Upside$54.36 Price TargetShort InterestBearish16.29% of Shares Sold ShortDividend StrengthN/ASustainability-0.64Upright™ Environmental ScoreNews Sentiment1.42Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.76) to ($1.18) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.02 out of 5 starsMedical Sector171st out of 910 stocksSurgical & Medical Instruments Industry23rd out of 95 stocks 4.4 Analyst's Opinion Consensus RatingTandem Diabetes Care has received a consensus rating of Moderate Buy. The company's average rating score is 2.81, and is based on 13 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageTandem Diabetes Care has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tandem Diabetes Care's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted16.29% of the outstanding shares of Tandem Diabetes Care have been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Tandem Diabetes Care has recently increased by 3.34%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldTandem Diabetes Care does not currently pay a dividend.Dividend GrowthTandem Diabetes Care does not have a long track record of dividend growth. Previous Next 4.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreTandem Diabetes Care has received a 80.42% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Insulin pumps" product. See details.Environmental SustainabilityThe Environmental Impact score for Tandem Diabetes Care is -0.64. Previous Next 2.5 News and Social Media Coverage News SentimentTandem Diabetes Care has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Tandem Diabetes Care this week, compared to 5 articles on an average week.Search InterestOnly 4 people have searched for TNDM on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Tandem Diabetes Care to their MarketBeat watchlist in the last 30 days. This is a decrease of -88% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tandem Diabetes Care insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.20% of the stock of Tandem Diabetes Care is held by insiders.Read more about Tandem Diabetes Care's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Tandem Diabetes Care are expected to grow in the coming year, from ($1.76) to ($1.18) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tandem Diabetes Care is -19.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tandem Diabetes Care is -19.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTandem Diabetes Care has a P/B Ratio of 11.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tandem Diabetes Care's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About Tandem Diabetes Care Stock (NASDAQ:TNDM)Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.Read More TNDM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TNDM Stock News HeadlinesAugust 29, 2024 | americanbankingnews.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Rating of "Moderate Buy" by BrokeragesAugust 28, 2024 | americanbankingnews.comTandem Diabetes Care (NASDAQ:TNDM) Now Covered by Analysts at Morgan StanleySeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.August 28, 2024 | investing.comTandem Diabetes Care Inc DRC (T2ND34)August 28, 2024 | americanbankingnews.comMorgan Stanley Begins Coverage on Tandem Diabetes Care (NASDAQ:TNDM)August 27, 2024 | finance.yahoo.comTandem Diabetes Care Announces Upcoming Conference ParticipationAugust 23, 2024 | msn.comMorgan Stanley Initiates Coverage of Tandem Diabetes Care (TNDM) with Equal-Weight RecommendationAugust 20, 2024 | finance.yahoo.comTandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide RecallSeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.August 17, 2024 | finance.yahoo.comTNDM Sep 2024 25.000 put (TNDM240920P00025000)August 15, 2024 | seekingalpha.comTandem Diabetes: Mobi's Surprise Sales Fail To Offset Flat Operating MarginAugust 14, 2024 | ca.finance.yahoo.comTNDM Sep 2024 42.500 putAugust 14, 2024 | ca.finance.yahoo.comTNDM Nov 2024 25.000 putAugust 13, 2024 | msn.comFDA Announces Update on Tandem Diabetes Care’s Recall of t:connect Mobile AppAugust 12, 2024 | ca.finance.yahoo.comTNDM Feb 2025 30.000 putAugust 12, 2024 | tmcnet.comTandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS DevicesAugust 9, 2024 | globenewswire.comTANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmAugust 9, 2024 | msn.comCanaccord Genuity Initiates Coverage of Tandem Diabetes Care (TNDM) with Buy RecommendationSee More Headlines Receive TNDM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/01/2024Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:TNDM CUSIPN/A CIK1438133 Webwww.tandemdiabetes.com Phone(858) 366-6900FaxN/AEmployees2,400Year Founded2006Price Target and Rating Average Stock Price Target$54.36 High Stock Price Target$75.00 Low Stock Price Target$39.00 Potential Upside/Downside+28.2%Consensus RatingModerate Buy Rating Score (0-4)2.81 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($2.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-222,610,000.00 Net Margins-17.15% Pretax Margin-16.50% Return on Equity-41.54% Return on Assets-12.17% Debt Debt-to-Equity Ratio1.31 Current Ratio3.05 Quick Ratio2.38 Sales & Book Value Annual Sales$796.00 million Price / Sales3.44 Cash FlowN/A Price / Cash FlowN/A Book Value$3.57 per share Price / Book11.88Miscellaneous Outstanding Shares64,590,000Free Float63,169,000Market Cap$2.74 billion OptionableOptionable Beta1.32 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. John F. Sheridan (Age 69)President, CEO & Director Comp: $988.35kMs. Leigh A. Vosseller (Age 50)Executive VP, CFO & Treasurer Comp: $543.38kMs. Susan M. Morrison (Age 45)Executive VP & Chief Administrative Officer Comp: $538.21kMr. David B. Berger Esq. (Age 54)Transitional Advisor Comp: $543.38kMr. Brian B. Hansen (Age 56)Executive Officer Comp: $561.74kMs. Elizabeth Anne Gasser (Age 48)Executive Vice President and Chief Strategy & Product Officer Comp: $542.91kMr. Mark Novara (Age 49)Executive VP & Chief Commercial Officer Comp: $169.6kMr. Rick A. Carpenter (Age 61)Chief Technical Officer Ms. Shannon M. Hansen (Age 58)Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary Mr. Tom FoxChief Human Resources OfficerMore ExecutivesKey CompetitorsHaemoneticsNYSE:HAEIntegra LifeSciencesNASDAQ:IARTICU MedicalNASDAQ:ICUINevroNYSE:NVROPenumbraNYSE:PENView All CompetitorsInsiders & InstitutionsTruist Financial CorpSold 4,300 shares on 8/21/2024Ownership: 0.167%Driehaus Capital Management LLCSold 362,193 shares on 8/16/2024Ownership: 1.479%Algert Global LLCBought 6,150 shares on 8/16/2024Ownership: 0.070%Creative PlanningBought 3,461 shares on 8/16/2024Ownership: 0.018%AQR Capital Management LLCBought 7,327 shares on 8/15/2024Ownership: 0.011%View All Insider TransactionsView All Institutional Transactions TNDM Stock Analysis - Frequently Asked Questions How have TNDM shares performed this year? Tandem Diabetes Care's stock was trading at $29.58 at the beginning of 2024. Since then, TNDM stock has increased by 43.3% and is now trading at $42.40. View the best growth stocks for 2024 here. How were Tandem Diabetes Care's earnings last quarter? Tandem Diabetes Care, Inc. (NASDAQ:TNDM) released its quarterly earnings data on Thursday, August, 1st. The medical device company reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($0.54) by $0.07. The firm's revenue for the quarter was up 13.3% compared to the same quarter last year. When did Tandem Diabetes Care's stock split? Tandem Diabetes Care shares reverse split on Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What is John Sheridan's approval rating as Tandem Diabetes Care's CEO? 11 employees have rated Tandem Diabetes Care Chief Executive Officer John Sheridan on Glassdoor.com. John Sheridan has an approval rating of 88% among the company's employees. Who are Tandem Diabetes Care's major shareholders? Tandem Diabetes Care's top institutional investors include Fred Alger Management LLC (3.32%), Driehaus Capital Management LLC (1.48%), Chicago Capital LLC (1.27%) and First Light Asset Management LLC (1.08%). Insiders that own company stock include Kim D Blickenstaff, Dick Allen, Leigh Vosseller, John F Sheridan, Kathleen Mcgroddy-Goetz, Brian B Hansen, Christopher J Twomey, David B Berger, Shannon Marie Hansen, Rebecca B Robertson, Elizabeth Anne Gasser, Susan Morrison and James Leal. View institutional ownership trends. How do I buy shares of Tandem Diabetes Care? Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Tandem Diabetes Care own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tandem Diabetes Care investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Micron Technology (MU), DexCom (DXCM), Netflix (NFLX) and Block (SQ). This page (NASDAQ:TNDM) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNDM Stock Alerts